Abstract:Background Hepatocellular carcinoma (HCC) stands out as a significant contributor to cancer-related death. Traditional Chinese Medicine (TCM) offers several advantages in the treatment of HCC. Britannin, a pivotal compound in Inulae Flos, has demonstrated pharmacological effects against various cancers, yet research on its specific anti-HCC effects remains limited. Purpose This study aims to explore the anti-HCC effects of britannin and its underlying mechanism. Methods MTT assay, clone formation assay and flow cytometry were utilized to detect the cell activity, proliferation ability and apoptosis of britannin against HCC cell lines. Cell migration and invasion abilities of HCC cell lines treated with britannin were evaluated by wound-healing assay and transwell migration and invasion assay. H22 xenografted tumor mouse model was constructed and britannin treatment was performed to observe the effect of britannin on HCC tumors. The expression levels of liver cancer biomarkers AFP, AFP-L3, APT and TGF-β were detected by Elisa, and the histopathology was observed by HE staining. Network pharmacology and molecular docking were used to predict the possible signaling pathway of anti-HCC effect of britannin. The surface plasmon resonance (SPR) experiment was used to verify the interaction between britannin and proteins. The cell kinase activity function experiment was employed to detect the effect of britannin on enzyme activity. RT-qPCR and Western-Blot were used to verify the effect of britannin on the mRNA expressions of key genes and protein levels related to GSK-3β/β-catenin pathway in HCC cells and tumor tissues in mice. Results In vitro experiments showed that britannin could inhibit the activity, proliferation, migration and invasion abilities of HCC cells, while promoting their apoptosis. In vivo experiments revealed that britannin exerted inhibitory effects on the growth of transplanted liver cancer tumors, reducing the inflammatory infiltration and the expression levels of AFP, AFP-L3, APT and TGF-β of liver cancer markers in transplanted mice. Network pharmacology and molecular docking predicted that cell adhesion factors and GSK-3β/β-catenin pathway might be the related signaling pathway and had potential docking activity with key proteins. The SPR experiments elucidated the molecular interaction between britannin and GSK-3β. Enzyme activity assays indicated that britannin could modulate the functional activity of GSK-3β kinase. RT-qPCR suggested britannin could regulate the mRNA expressions of β-catenin, GSK-3β, E-cadherin and NCadherin. Western-Blot further verified that britannin could significantly up-regulate the expression of GSK-3β and down-regulate the expression of p -GSK-3β and β-catenin. At the same time, the expression of E-cadherin increased and NCadherin decreased, thereby reducing the occurrence of EMT and inhibiting the metastasis of HCC. Conclusion In conclusion, britannin could inhibit the growth, development and metastasis of HCC, and its mechanism may be related to the regulation of GSK-3β/β-catenin signaling pathway to inhibit epithelial-mesenchymal transition of HCC.

A Natural Sesquiterpene Inhibits Lung Cancer Proliferation and Metastasis by Regulating Stat3 and Fak Signal Pathway

Britannin inhibits cell proliferation, migration and glycolysis by downregulating KLF5 in lung cancer

A Natural Xanthone Suppresses Lung Cancer Growth and Metastasis by Targeting STAT3 and FAK Signaling Pathways

PUB045 Anti-Tumor Effect of Honokiol in Lung Squamous Cell Carcinoma

Britannin stabilizes T cell activity and inhibits proliferation and angiogenesis by targeting PD-L1 via abrogation of the crosstalk between Myc and HIF-1α in cancer

Britanin Exhibits Potential Inhibitory Activity on Human Prostate Cancer Cell Lines Through PI3K/Akt/NF-κB Signaling Pathways

Britannin inhibits hepatocellular carcinoma development and metastasis through the GSK-3β/β-catenin signaling pathway

The Antitumor Effects of Britanin on Hepatocellular Carcinoma Cells and Its Real-time Evaluation by in Vivo Bioluminescence Imaging.

A Novel Natural Product, Britanin, Inhibits Tumor Growth of Pancreatic Cancer by Suppressing Nuclear Factor-Κb Activation.

Isoliquiritigenin: A Natural Compound with a Promising Role in Inhibiting Breast Cancer Lung Metastasis

In Vivo Antitumour Activity of Britanin Against Gastric Cancer Through Nuclear Factor-Κb-mediated Immune Response.

Anti-tumor Effects and Mechanisms of Sesamin on Lewis Lung Cancer in C_(57)BL/6 Mice

HJC0152 Suppresses Human Non-Small-cell Lung Cancer by Inhibiting STAT3 and Modulating Metabolism.

A Ferulic Acid Derivative FXS-3 Inhibits Proliferation and Metastasis of Human Lung Cancer A549 Cells via Positive JNK Signaling Pathway and Negative ERK/p38, AKT/mTOR and MEK/ERK Signaling Pathways

Mechanistic and Therapeutic Study of Novel Anti-Tumor Function of Natural Compound Imperialine for Treating Non-Small Cell Lung Cancer

Three Sesquiterpene Lactones Suppress Lung Adenocarcinoma by Blocking TMEM16A-mediated Ca2+-activated Cl- Channels.

Cratoxylumxanthone C, a Natural Xanthone, Inhibits Lung Cancer Proliferation and Metastasis by Regulating STAT3 and FAK Signal Pathways.

Paeonol Suppresses Proliferation and Motility of Non-Small-Cell Lung Cancer Cells by Disrupting STAT3/NF-κB Signaling

Telocinobufagin Has Antitumor Effects in Non-Small-Cell Lung Cancer by Inhibiting STAT3 Signaling

Sesquiterpene Binding Gly-Leu-Ser/Lys-"co-adaptation Pocket" to Inhibit Lung Cancer Cell Epithelial-Mesenchymal Transition.

A New Semisynthetic 1- O -Acetyl-6- O -Lauroylbritannilactone Induces Apoptosis of Human Laryngocarcinoma Cells Through P53-Dependent Pathway